The FDA recently revised the EUA for Merck’s Covid-19 pill molnupiravir, explaining that it should only be used as a last line of defense if other treatments are available, including Pfizer’s pill Paxlovid, which posted […]
Pushing the envelope on next-gen CAR-T drugs, researchers running an early-stage trial on a 2.0-style cancer therapy at Memorial Sloan Kettering Cancer Center have hit the red light on enrollment for now as they probe […]
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is still shaping […]
Dupixent, the seemingly infallible anti-inflammatory drug jointly developed by Regeneron and Sanofi, has flopped in a Phase III study. Given to patients with chronic spontaneous urticaria — a condition characterized by the constant presence of […]
GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal ntaylor Fri, 02/18/2022 – 05:04 Click here to view original post
Five years ago, in a span of less than two months, four drug companies simultaneously converged on a single new way to treat obesity. It was a curious scientific journey. More than a decade prior, an […]
TARRYTOWN, N.Y.: TARRYTOWN, N.Y., Feb. 17, 2022 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows: Cowen 42nd Annual Health Care Conference at 1:30 p.m. ET on Tuesday, March 8, 2022 […]
ASCO GU: Bayer tees up another 3-way battle against Pfizer-Astellas, J&J with new Nubeqa prostate cancer data aliu Thu, 02/17/2022 – 12:22 Click here to view original post
Citing its commitment to equitable vaccine access, Moderna pledged early on that it wouldn’t enforce its Covid-related IP rights while the pandemic is ongoing. But with talks of an endemic phase approaching, some worry South […]
The US district court of Delaware handed AstraZeneca a victory late Wednesday, effectively setting aside a violation letter sent by President Biden’s Health Resources and Services Administration for the company’s failure to comply with its […]
Copyright © 2022 Biotech Networks, LLC
